ÌÇÐÄ´«Ã½

The AAI Public Policy Fellows Program (PPFP)

The PPFP provides early-career researchers, who are within 15 years of receiving their terminal degree and who are committed to a career in biomedical research, with the opportunity to learn more about how critical funding and science policy decisions are made and how individual scientists can use their voice to make a difference in the laws and policies that affect science. Fellows also get the opportunity to participate in the public policy and legislative activities of AAI. Up to 10 Fellows are selected to participate annually.

Fellows serve from May 1st of their selection year to April 30th of the following year. The program kicks off at the annual meeting and culminates in a two-day Capitol Hill Day program in Washington, D.C., where Fellows meet with their congressional representatives to advocate for support for immunological research and increased funding for NIH. Besides these two events, Fellows do not have to leave their jobs or institutions.


Program Goals

The primary goals of the program are to 1) help AAI members, early in their careers, better understand the role of the President and Administration, Congress, and the National Institutes of Health in determining the policies that affect biomedical research; and 2) teach participants how best to advocate for the funding and policies that impact their careers. The program will also help ensure that AAI has within its ranks a cadre of well-informed scientists who can help lead the organization's public policy efforts in the future. Former Fellows often go on to serve AAI in myriad other capacities, including as members of the AAI Committee on Public Affairs.
 

Program Description

Program Components
  1. Capitol Hill Day: Fellows come to Washington, DC, for a two-day Capitol Hill Day program (likely in March). They attend a training session with AAI staff and visit their Congressional representatives to advocate for biomedical research and increased funding for NIH. AAI pays for Fellows' flights, hotel, and other reasonable expenses (per the AAI Volunteer Travel Policy).
  2. AAI Annual Meeting Program: Fellows attend the AAI annual meeting (during their Fellowship year), including any public policy or PPFP sessions requested by AAI. Attendance at the meeting is at the Fellows' expense. Fellows may apply for and use any AAI travel awards for which they are eligible.
  3. Communication with AAI: Members of the AAI Committee on Public Affairs and AAI government affairs staff communicate with the Fellows by email and monthly video conference calls during their Fellowship year to keep them informed and to solicit their views on key topics.
  4. Special Projects: Fellows have the opportunity to contribute to public policy and legislative activities throughout their fellowship year. Examples include drafting sections of the AAI congressional testimony and revising the AAI Advocacy Brochure.
Qualifications
All PPFP Fellows are selected by the AAI Committee on Public Affairs. Applicants are required to:
  • have received their Ph.D. or M.D. (or equivalent) within the previous 15 years in immunology or a related field
  • be a member in good standing of AAI (must be a member at the time of application and throughout the Fellowship year)
  • be committed to a career in biomedical research
  • have excellent interpersonal and communication skills
  • have an interest in public policy as it relates to biomedical research
  • live and work in the United States and
  • submit by the designated deadline three electronic web forms:
    1. the
    2. two references from AAI members (regular members in good standing who do not serve on the AAI Council or AAI Committee on Public Affairs) using the

Fellows

Bencomo-Alvarez

Alfonso Bencomo-Alvarez, Ph.D.

St. Jude Children’s Research Hospital (Tennessee)

I’m deeply honored and thrilled to have been selected as one of the 2025–2026 AAI Public Policy Fellows! This incredible opportunity marks a meaningful milestone in my journey as a biomedical researcher and passionate advocate for equitable health outcomes. I firmly believe that bridging the gap between science and public policy is essential for advancing biomedical research and improving public health. Participating in the AAI PPFP will provide me with the tools, knowledge, and network to better advocate for the policies and funding needed to support innovative immunological research. I’m incredibly grateful to AAI for this opportunity, and I look forward to contributing to the important policy conversations that shape the future of biomedical science.
Bou-Dargham

Mayassa Bou-Dargham, Ph.D.

University of Pennsylvania

I am honored and excited to accept the AAI Public Policy Fellowship. I’m deeply grateful for the opportunity to gain first-hand experience at the intersection of science and policy. As a scientist, I believe it is critical to engage beyond the bench—to contribute meaningfully to the conversation around science-informed policy. I recognize the importance of clear, accessible, and evidence-based communication of scientific findings to non-scientific audiences. This fellowship presents a unique opportunity to learn how policies that impact science and public health are developed—and how scientists can engage constructively with policymakers to advocate for informed, evidence-based decisions. Through this experience, I hope to better understand how to translate complex scientific ideas into clear, compelling messages that can support sound public policy and foster public trust. I look forward to contributing to and being part of the program.
Cheung

Cherry Cheuk Lam Cheung, M.Sc., Ph.D.

Indiana University School of Medicine

I’m deeply honored to be selected as a 2025–2026 AAI Public Policy Fellow, especially during such a critical time for the scientific community. Now more than ever, it is essential for immunologists and scientists to engage in policy conversations and advocate for evidence-based decision-making. I look forward to contributing to the missions of AAI, learning from experienced policy professionals, and working alongside like-minded fellows to amplify the voice of science in shaping public policy.
Delery

Elizabeth Delery, Ph.D.

Marian University (Indiana)

I am ecstatic and incredibly honored to have been selected as an AAI Public Policy Fellow for the 2025-2026 cohort. In a time when scientific misinformation is at an all-time high and there is a rise in vaccine preventable illnesses and deaths, I hope to play a part in rebuilding trust in science and the scientific community amongst politicians and the general public. I was incredibly privileged to be raised by parents who encouraged my love of science and study under educators who encouraged my never-ending questions. I am eager to pay that forward by making science and immunology more accessible to the policymakers making decisions for the betterment of the United States health infrastructure. I am most excited to gain a deeper understanding regarding the policies and procedures of science policymaking and getting a chance to interact and learn from the policymakers themselves. I look forward to working with this new cohort and the rest of the immunology community. Thank you, AAI!
Holl

Jordan Holl, Ph.D.

Wadsworth New York State Department of Health

I am deeply humbled to be selected as a participant in this year's Public Policy Fellows Program. I've had quite the research journey, having received my M.Sc. in Japan and being selected as a European Union Marie Curie Co-fellow and elected university chairman of the program, among other highlights. I hope to utilize these unique international and administrative experiences in service to the program and my peers. The PPFP's goal of educating scientists on the inner workings of governmental policy – such a crucial yet rarely explored aspect of a typical researcher's career – strikes me as a supremely worthy pursuit. As a field, we have seen recent technological advancement which has led to greatly improved clinical outcomes in a variety of diseases, as well as a deeper fundamental understanding of the role that niche immunological elements play in a variety of pathologies. I am eager to understand the nuts and bolts of public policy advocacy, and to learn the most effective means by which policy can be influenced for the pursuit of knowledge.
Joldrichsen

Marisa Joldrichsen, Ph.D.

The Ohio State University

I am honored to be selected as a member of the AAI Public Policy Fellows Program for 2025-2026. In recent years we have seen an increase in scientific misinformation and the politicization of biomedical research, I believe that it is more important than ever that scientific experts are upfront and vocal about biomedical research and the funding needs required for the advancement of human health. I am excited for the opportunity to put this belief into practice by learning more about policy advocation and effective communication techniques with a non-scientific audience to better communicate the importance of biomedical research funding. I look forward to working and learning with my fellow PPFP peers on these skills and many others. Thank you, AAI, for this amazing opportunity.
Saunders

Ian Saunders, Ph.D.

Johnson & Johnson (Pennsylvania)

I am deeply honored and grateful to be selected as a 2025–2026 AAI Public Policy Fellow. This prestigious program offers early-career researchers like myself with a valuable opportunity to gain deeper insights into science policy and become stronger advocates for sustained funding across all sectors of biomedical research. As a scientist with a background in cancer research and drug development, I am passionate about advancing science-driven solutions that improve health outcomes and promote equitable access to care. As a new fellow, I am particularly excited about the program’s emphasis on science advocacy and innovation to ensure that scientific discoveries are not only supported at the policy level but are also translated into real-world impact. I look forward to taking full advantage of the program’s various learning and networking opportunities to strengthen my voice beyond the bench and become a more effective resource for my community.
Seeger

Allison Seeger, Ph.D.

University of Texas at Austin

I am thrilled to take part in the 2025-2026 AAI PPFP and honored to be selected this year, of all years, to advocate for evidence-based policy decisions. In this divisive moment, it is critical for scientists to engage our communities in health policy discussions and collaborate with legislators to navigate the disconnect between scientists, the government, and the public. I am humbled to learn just how to do that from the esteemed experts within AAI. I can’t wait to hone my science communication skills, network with local and national lawmakers, and share what I’ve learned with my lab mates. I am especially interested in exploring the One Health space, where biomedical and agricultural policy must meet to ensure the health of both our people and our planet.
Singh

Tulika Singh, Ph.D.

University of California, Berkeley

"I am honored to be selected as a 2025-26 AAI Public Policy Fellow. I study human immune responses that protect us against infectious diseases to promote health through vaccines and therapies. Through past advocacy efforts, I helped successfully establish a multilateral global fund enabling countries to strengthen their health infrastructure and enhance pandemic preparedness. This big achievement shows me the importance of educating and building relationships with policymakers to protect communities. I am deeply committed to science communication, global health equity, and ensuring that all members of our community can participate in research and access the fruits of scientific innovation. I look forward to working with my colleagues at AAI and will strive to protect funding for research, promote access to lifesaving innovations, and train the next generation of immunologists. Thank you for this opportunity, AAI!"
Verma

Sheetal Verma, Ph.D.

Rutgers University - New Jersey Medical School

I am deeply honored to have been selected for the American Association of Immunologists (AAI) Public Policy Fellows Program (PPFP). This opportunity aligns perfectly with my commitment to leveraging scientific research and public policy to address critical global health challenges, particularly infectious diseases like Tuberculosis (TB). In addition to an urgent need for innovative prevention, diagnosis, and treatment strategies, infectious disease research can benefit greatly from public policy engagement. Through the PPFP, I look forward to interacting with policymakers and contributing to evidence-based strategies that further promote health equity in biomedical research.
Mark Brimble
Mark Brimble, Ph.D.
St. Jude Children’s Research Hospital
Brennah Britten
Brennah Britten, Ph.D.
The Wistar Institute
Douglas Chung
Douglas Chung, Ph.D.
Genentech
David Constant
David Constant, Ph.D.
Oregon Health & Science University
Neha Dubey
Neha Dubey, Ph.D.
Washington University in St. Louis
Patricia Ferrer Castillo
Patricia Ferrer Castillo, Ph.D.
Uniformed Services University of the Health Sciences
Henry M. Jackson Foundation for the Advancement of Military Medicine
Rebekah Kendall
Rebekah Kendall, Ph.D.
The University of Montana
Jillian L. McCool
Jillian L. McCool, Ph.D.
Lawrence Livermore National Lab
Gianluca Veggiani
Gianluca Veggiani, Ph.D.
Louisiana State University
Insha Zahoor
Insha Zahoor, Ph.D. Henry Ford Health
Mafalda de Arrábida Farelo
Mafalda de Arrábida Farelo, Ph.D.
City of Hope
Heather Gustafson
Heather Gustafson, Ph.D.
Seattle Children's Research Institute
Anne Hahn
Anne Hahn, Ph.D.
Yale School of Public Health
Emma Hornick
Emma Hornick, Ph.D.
University of Iowa
Nicholas Maurice
Nicholas Maurice, Ph.D.
University of Minnesota
Srinivasu Mudalagiriyappa
Srinivasu Mudalagiriyappa, D.V.M., Ph.D.
Amgen
Amali Samarasinghe
Amali Samarasinghe, Ph.D.
University of Tennessee Health Sciences Center
Derek Theisen
Derek Theisen, Ph.D.
Washington University in St. Louis
Sarah Webster
Sarah Webster, Ph.D.
Western Michigan University Homer Stryker M.D. School of Medicine
Samantha Yeligar
Samantha Yeligar, Ph.D.
Emory University
Adeleye Adeshakin
Adeleye Adeshakin, Ph.D.
St. Jude Children’s Research Hospital
Adriana Benavides
Adriana Benavides, Ph.D.
American Association for Cancer Research
Jeremy Crawford
Jeremy Crawford, Ph.D.
St. Jude Children’s Research Hospital
Caroline Jones
Caroline Jones, Ph.D.
University of Texas at Dallas
Jamie McCall
Jamie McCall, Ph.D.
West Virginia University
Chandra Menendez
Chandra Menendez, Ph.D.
University of Oklahoma Health Sciences Center
Victoria Mutua
Victoria Mutua, D.V.M., Ph.D.
University of California, Davis
Ninecia Scott
Ninecia Scott, Ph.D.
Centers for Disease Control and Prevention
Erin Taylor
Erin Taylor, Ph.D.
University of Mississippi Medical Center
,
Year Recipient Sort Name
2021-2022 Todd Bradley, Ph.D. Bradley
2021-2022 Virginia Camacho, Ph.D. Camacho
2021-2022 Victor Cortez, Ph.D. Cortez
2021-2022 Meredith Crane, Ph.D. Crane
2021-2022 Mary Fontana, Ph.D. Fontana
2021-2022 Teresia Maina, Ph.D. Maina
2021-2022 Cody McHale, Ph.D. McHale
2020-2021 S. Elizabeth Franks, Ph.D. Franks
2020-2021 Erin M. Harberts, Ph.D. Harberts
2020-2021 April Huseby Kelcher, Ph.D. Kelcher
2020-2021 Peter D. Krueger, Ph.D. Krueger
2020-2021 Brina Lopez, D.V.M., Ph.D. Lopez
2020-2021 Joshua T. Mattila, Ph.D. Mattila
2020-2021 Parameswaran Ramakrishnan, Ph.D. Ramakrishnan
2020-2021 Julia M. Scordo, Ph.D. Scordo
2020-2021 Shipra Vaishnava, Ph.D. Vaishnava
2020-2021 Tayab Waseem, Ph.D. Waseem
2019-2020 Ty Crowl, Ph.D. Crowl
2019-2020 Magdia De Jesus, Ph.D. De Jesus
2019-2020 Nicholas Hess, Ph.D. Hess
2019-2020 Rebecca Hesterberg, Ph.D. Hesterberg
2019-2020 Weishan Huang, Ph.D. Huang
2019-2020 Peter Morawski, Ph.D. Morawski
2019-2020 Dennis Neeld, Ph.D. Neeld
2019-2020 Shailbala Singh, D.V.M., Ph.D. Singh
2019-2020 Anibal Valentin-Acevedo, Ph.D. Valentin-Acevedo
2019-2020 Leah Wuescher, Ph.D. Wuescher
2018-2019 Nathaniel H. Boyd, Ph.D. Boyd
2018-2019 Gavin H. Imperato, M.D. Imperato
2018-2019 Liz McMichael, Ph.D. McMichael
2018-2019 Gregory Szeto, Ph.D. Szeto
2018-2019 Francisco R. Victorino, Ph.D. Victorino
2018-2019 Emily A. Hemann, Ph.D. Hemann
2018-2019 Jesica R. Jacobs, Ph.D. Jacobs
2018-2019 Mallory L. Paynich, Ph.D. Paynich
2018-2019 Stina L. Urban, Ph.D. Urban
2018-2019 Melody Y. Zeng, Ph.D. Zeng
2016-2017 Mufadhal Al-Kuhlani, Ph.D. Al-Kuhlani
2016-2017 Eyal Amiel, Ph.D. Amiel
2013-2014 Rachel Bergerson, Ph.D. Bergerson
2014-2015 Matthew Billard, Ph.D. Billard
2013-2014 Jennifer (Lori) Blanchfield, Ph.D. Blanchfield
2014-2015 C. Colin Brinkman, Ph.D. Brinkman
2015-2016 Tullia Bruno, Ph.D. Bruno
2016-2017 Kristina Burrack, Ph.D. Burrack
2011-2012 Judy Cannon, Ph.D. Cannon
2012-2013 Ling Cao, M.D., Ph.D. Cao
2011-2012 Devavani Chatterjea, Ph.D. Chatterjea
2016-2017 Michael Constantinides, Ph.D. Constantinides
2016-2017 Stacey Cranert, Ph.D. Cranert
2014-2015 Ryan Cummings, Ph.D. Cummings
2014-2015 Jonathan Deane, Ph.D. Deane
2013-2014 Gretchen Diehl, Ph.D. Diehl
2015-2016 Jason Gigley, Ph.D. Gigley
2012-2013 Kory Hallett, Ph.D. Hallett
2015-2016 Nichol Holodick, Ph.D. Holodick
2013-2014 Katrina Hoyer, Ph.D. Hoyer
2011-2012 Shawn Jackson, Ph.D. Jackson
2012-2013 Stephanie James, Ph.D. James
2011-2012 Kamal Khanna, Ph.D. Khanna
2014-2015 Heather Kling, Ph.D. Kling
2015-2016 David Larson, Ph.D. Larson
2013-2014 Elizabeth Leadbetter, Ph.D. Leadbetter
2011-2012 Linda Lieberman, Ph.D. Lieberman
2015-2016 Nicole Perry Lieberman, Ph.D. Lieberman
2016-2017 Jacquelyn Lykken, Ph.D. Lykken
2015-2016 Jean Nepomuscene Manirarora, D.V.M., Ph.D. Manirarora
2015-2016 Meghan ²Ñ²¹°ù°ùé, Ph.D. ²Ñ²¹°ù°ùé
2011-2012 Jeffrey Mills, Ph.D. Mills
2011-2012 Amy Moran, Ph.D. Moran
2012-2013 Joshua Obar, Ph.D. Obar
2014-2015 Shaun O'Brien, Ph.D. O'Brien
2014-2015 Karen O'Connell Martins, Ph.D. O'Connell Martins
2011-2012 Anastazia Older Aguilar, Ph.D. Older Aguilar
2012-2013 Hannah Phipps-Yonas, Ph.D. Phipps-Yonas
2014-2015 Rebecca Pompano, Ph.D. Pompano
2012-2013 Melanie Ragin, Ph.D. Ragin
2014-2015 Sesquile Ramon, Ph.D. Ramon
2016-2017 Srinika Ranasinghe, Ph.D. Ranasinghe
2012-2013 Jillian Richmond, Ph.D. Richmond
2012-2013 Mark Rubinstein, Ph.D. Rubinstein
2013-2014 Surojit Sarkar, Ph.D. Sarkar
2013-2014 Jeremy Schaefer, Ph.D. Schaefer
2013-2014 Brian Sheridan, Ph.D. Sheridan
2012-2013 Adam Soloff, Ph.D. Soloff
2014-2015 Stefanie Sowinski, Ph.D. Sowinski
2015-2016 Erica Stone, Ph.D. Stone
2016-2017 Rachel Temple, Ph.D. Temple
2013-2014 Tamisha Vaughan, Ph.D. Vaughan
2015-2016 Joshua Vieth, Ph.D. Vieth
2016-2017 Lavanya Visvabharathy, Ph.D. Visvabharathy
2013-2014 Stephanie Watkins, Ph.D. Watkins
2012-2013 Dina Weilhammer, Ph.D. Weilhammer
2011-2012 Eric Weimer, Ph.D. Weimer
2015-2016 Jessica Werner, Ph.D. Werner
2011-2012 Caleph Wilson, Ph.D. Wilson
2016-2017 Mary Young, Ph.D. Young
2017-2018 Heather Marie Buechel, Ph.D. Buechel
2017-2018 David J. Dowling, Ph.D. Dowling
2017-2018 Mariana Guerra-Maupome, D.V.M., Ph.D. Guerra-Maupome
2017-2018 Farrah C. Phillips, Ph.D. Phillips
2017-2018 Rachel S. Resop, Ph.D. Resop
2017-2018 Timothy Rosean, Ph.D. Rosean
2017-2018 Nathaniel Schuldt, Ph.D. Schuldt
2017-2018 Julie Swartzendruber, Ph.D. Swartzendruber
2017-2018 Melissa M. Walker, Ph.D. Walker
2017-2018 Spencer C. Wei, Ph.D. Wei

© ÌÇÐÄ´«Ã½ Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650, Rockville, Maryland 20852
(301) 634-7178 | infoaai@aai.org